Welcome to REPO4EU: Core Insights
Our brand new article series where we bring you closer to our project's core innovations and results.
The REPO4EU platform
A brief introduction
At the heart of REPO4EU lies a bold ambition: to build a cutting-edge, modular, and user-friendly digital platform that empowers researchers, clinicians, and regulators to collaboratively drive drug repurposing efforts in a structured and scalable way. Our goal is to provide the technical backbone for the entire REPO4EU ecosystem —a place where tools, data, methodologies, and collaborations converge to streamline and accelerate repurposing workflows across Europe.
The platform will not only integrate existing computational tools and data resources, but also serve as a dynamic workspace where users can conduct complex in-silico analyses, access curated scientific databases, and examine comprehensive research documentation to ensure transparency and reproducibility. An integrated matchmaking system enhances this environment by fostering interdisciplinary collaboration and connecting users with relevant expertise, tools, and data.
Built on principles of transparency, FAIR data, and cross-disciplinary usability, the REPO4EU platform aims to redefine how repurposing research is conducted and transformed into actionable insights.

The road so far
A quick walk through the development journey
The requirement-gathering phase for the platform was successfully completed last summer, providing us with a clear and validated understanding of user needs. These initial insights have shaped the ongoing technical implementation and ensured the platform is built around actual use cases.
The focus so far has been on the development of the platform’s core components that will support long-term functionality and scalability. This includes the implementation of a robust backend architecture, a flexible Content Management System (CMS), an interactive decision tree engine component to support guided user workflows, a curated database module for structured resource management, and the foundation for a platform assistant to support user navigation.
The most immediate challenge now is ensuring the platform can adapt to the wide variety of tools, datasets, and user needs; each with different technical expectations and degrees of complexity. Unlocking compliance, scalability, and performance without compromising security, and balancing flexibility with usability is a constant priority. On top of this, rapid developments in AI and data privacy require careful technical and ethical considerations as we implement features like AI-powered assistance or advanced analytics.

Looking ahead
The driving force - Putting together the pieces of the drug repurposing puzzle
The strong interdisciplinary nature of REPO4EU remains our strongest motivation. Collaborating with experts in regulatory science, pharmacology, bioinformatics, and clinical practice has been energizing, and it keeps our focus grounded in real impact. After all, our biggest hope is to create a platform that doesn’t just serve today’s needs, but is able to grow into a sustainable digital infrastructure for drug repurposing across Europe and beyond.
The opportunity to see the platform evolve into a truly user-centric, interoperable ecosystem that enables researchers, clinicians, and decision-makers to collaborate and innovate more efficiently in the field of drug repurposing is what excites us the most moving forward. With so many diverse tools and resources being integrated, and the emergence of new technologies like AI-driven assistants, we see REPO4EU becoming a key enabler for next-generation, evidence-based medicine.
We believe that bringing complex workflows, such as in-silico modeling, sustained by a solid research collection and a navigable network of drug repurposing prior art into a unified interface that doesn’t overwhelm users but instead guides them through well-structured, meaningful paths could genuinely lower the barrier to entry for impactful research and accelerate the path from idea to implementation, especially in the drug repurposing realm.
The recent momentum in generative AI has also opened exciting new directions. To better support users navigating these repurposing workflows, we are now developing an AI Assistant Chatbot. This assistant will help users find the right tools, resources, and data based on natural language queries, significantly improving user experience, accessibility and encouraging meaningful engagement.
At the same time, we are aware of the massive challenge of stitching all these components together in a way that’s both technically robust and intuitive to use. Ensuring scalability, long-term maintainability, and data governance compliance while staying agile and user-driven is a constant balancing act. After all, we understand that successful adoption hinges not only on specific features but on clarity, performance, and trust — all factors that require continuous fine-tuning and community feedback.

Behind the scenes
Meet our development team
The platform development team, led by Egnosis, is responsible for the overall design, technical development, and iterative rollout of the platform. Their expertise lies in systems integration, data architecture, workflow design, and user-centered software engineering. They act as both developers and facilitators, and transform scientific needs into working, scalable tools.
Key contributors to this effort include experts in cloud-based infrastructure, data modelling, secure user access, and research software engineering. The development team works hand-in-hand with REPO4EU partners across the whole consortium to ensure the platform not only meets technical requirements but also aligns with the practical workflows of its users.
About our platform
Discover our platform and explore its key features
Become an early tester now!
Follow the link to sign up for our platform's alpha release
